{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:03Z","timestamp":1793413923696,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,2,18]],"date-time":"2021-02-18T00:00:00Z","timestamp":1613606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Microbiol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s10123-021-00162-4","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T18:49:03Z","timestamp":1613760543000},"page":"251-262","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["In vitro antibiofilm efficacy of farnesol against Candida species"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2690-2769","authenticated-orcid":false,"given":"Mihrinur","family":"Yap\u0131c\u0131","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6822-3484","authenticated-orcid":false,"given":"B\u00fckay Yenice","family":"G\u00fcrsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-8653","authenticated-orcid":false,"given":"\u0130lknur","family":"Da\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,18]]},"reference":[{"key":"162_CR1","doi-asserted-by":"publisher","first-page":"104987","DOI":"10.1016\/j.chemphyslip.2020.104987","volume":"233","author":"CF Bezerra","year":"2020","unstructured":"Bezerra CF, de Alencar J\u00fanior JG, de Lima HR, Dos Santos ATL, Pereira da Silva JC, Gusm\u00e3o da Silva T, Leal ALAB, Rocha JE, de Freitas TS, Tavares Vieira TA, Bezerra MCF, Sales DL, Kerntopf MR, de Araujo DG, Filho JMB, Peixoto LR, Pinheiro AP, Ribeiro-Filho J, Coutinho HDM, Morais-Braga MFB, Gon\u00e7alves da Silva T (2020) Antifungal activity of farnesol incorporated in liposomes and associated with fluconazole. Chem Phys Lipids 233:104987. https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.104987","journal-title":"Chem Phys Lipids"},{"key":"162_CR2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fmed.2018.00028","volume":"5","author":"M Cavalheiro","year":"2018","unstructured":"Cavalheiro M, Teixeira MC (2018) Candida biofilms: threats, challenges, and promising strategies. Front Med 5:28","journal-title":"Front Med"},{"issue":"6","key":"162_CR3","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12223-016-0456-9","volume":"61","author":"AA Chavez-Dozal","year":"2016","unstructured":"Chavez-Dozal AA, Nourabadi N, Erken M, McDougald D, Nishiguchi MK (2016) Comparative analysis of quantitative methodologies for Vibrionaceae biofilms. Folia Microbiol 61(6):449\u2013453","journal-title":"Folia Microbiol"},{"key":"162_CR4","unstructured":"Clinical and Laboratory Standards Institute (National Committee for Clinical Laboratory Standards)(2002)\u00a0Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved StandardM27-A2, 2nd ed, NCCLS: Wayne, PA, USA"},{"issue":"8","key":"162_CR5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/mmy\/myy160","volume":"57","author":"RDA Cordeiro","year":"2019","unstructured":"Cordeiro RDA, Pereira LMG, de Sousa JK, Serpa R, Andrade ARC, Portela FVM, Evangelista AJJ, Sales JA, Aguiar ALR, Mendes PBL at al. (2019) Farnesol inhibits planktonic cells and antifungal-tolerant biofilms of Trichosporon asahii and Trichosporon inkin. Med Mycol 57(8):1038\u20131045","journal-title":"Med Mycol"},{"issue":"3","key":"162_CR6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3390\/microorganisms7030073","volume":"7","author":"L Corte","year":"2019","unstructured":"Corte L, Casagrande Pierantoni D, Tascini C, Roscini L, Cardinali G (2019) Biofilm specific activity: a measure to quantify microbial biofilm. Microorganisms 7(3):73","journal-title":"Microorganisms"},{"key":"162_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.2174\/1874285801105010119","volume":"5","author":"N Decanis","year":"2011","unstructured":"Decanis N, Tazi N, Correia A, Vilanova M, Rouabhia M (2011) Farnesol, a quorum-sensing molecule triggers Candida albicans morphological changes by downregulating the expression of different secreted aspartyl proteinase genes. Open Microbiol J 5:119\u2013126","journal-title":"Open Microbiol J"},{"issue":"13","key":"162_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-8-13","volume":"8","author":"LS Derengowski","year":"2009","unstructured":"Derengowski LS, De-Souza-Silva C, Braz SV, Mello-De-Sousa TM, Bao SN (2009) Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann Clin Microbiol Antimicrob 8(13):13","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"162_CR9","first-page":"307","volume":"72","author":"S Dizova","year":"2017","unstructured":"Dizova S, Bujdakova H (2017) Properties and role of the quorum sensing molecule farnesol in relation to the yeast Candida albicans. Pharmazie 72:307\u2013312","journal-title":"Pharmazie"},{"issue":"8","key":"162_CR10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/322972","volume":"33","author":"RM Donlan","year":"2001","unstructured":"Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33(8):1387\u20131392","journal-title":"Clin Infect Dis"},{"issue":"1","key":"162_CR11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0966-842X(02)00002-1","volume":"11","author":"LJ Douglas","year":"2003","unstructured":"Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11(1):30\u201336","journal-title":"Trends Microbiol"},{"key":"162_CR12","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1111\/1462-2920.12448","volume":"16","author":"M Fazli","year":"2014","unstructured":"Fazli M, Almblad H, Rybtke ML, Givskov M, Eberl L, Tolker-Nielsen T (2014) Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ Microbiol 16:1961\u20131981. https:\/\/doi.org\/10.1111\/1462-2920.12448","journal-title":"Environ Microbiol"},{"issue":"3","key":"162_CR13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/08927014.2016.1144053","volume":"32","author":"RA Fernandes","year":"2016","unstructured":"Fernandes RA, Monteiro AR, Arias LS, Fernandes GL, Delbem ACB, Barbosa DB (2016) Biofilm formation by Candida albicans and Streptococcus mutans in the presence of farnesol: a quantitative evaluation. Biofouling 32(3):329\u2013338","journal-title":"Biofouling"},{"key":"162_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11046-013-9638-z","volume":"175","author":"AV Ferreira","year":"2013","unstructured":"Ferreira AV, Prado CG, Carvalho RR, Dias KS, Dias AL (2013) Candida albicans and Non-C. albicans Candida Species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections. Mycopathologia 175:265\u2013272","journal-title":"Mycopathologia"},{"issue":"8-9","key":"162_CR15","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.micinf.2009.04.018","volume":"11","author":"F Hasan","year":"2009","unstructured":"Hasan F, Xess I, Wang X, Jain N, Fries BC (2009) Biofilm formation in clinical Candida isolates and its association with virulence. Microbes Infect 11(8-9):753\u2013761","journal-title":"Microbes Infect"},{"issue":"11","key":"162_CR16","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.3390\/molecules23112827","volume":"23","author":"YY Jung","year":"2018","unstructured":"Jung YY, Hwang ST, Sethi G, Fan L, Arfuso F, Ahn KS (2018) Potential anti-inflammatory and anti-cancer properties of farnesol. Molecules 23(11):2827","journal-title":"Molecules"},{"issue":"2","key":"162_CR17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dku374","volume":"70","author":"A Katragkou","year":"2015","unstructured":"Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ (2015) In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms. J Antimicrob Chemother 70(2):470\u2013478","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"162_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jof6030099","volume":"6","author":"R Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs R, Majoros L (2020) Fungal quorum-sensing molecules: a review of their antifungal effect against Candida Biofilms. J Fungi 6(3):99","journal-title":"J Fungi"},{"issue":"5","key":"162_CR19","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ijch.201500025","volume":"56","author":"BP Krom","year":"2016","unstructured":"Krom BP, Levy N, Meijler MM, Jabra-Rizk MA (2016) Farnesol and Candida albicans: quorum sensing or not quorum sensing? Israel J Chem 56(5):295\u2013301","journal-title":"Israel J Chem"},{"issue":"5","key":"162_CR20","doi-asserted-by":"crossref","first-page":"e02307","DOI":"10.1128\/mBio.02307-19","volume":"10","author":"L Kunyeit","year":"2019","unstructured":"Kunyeit L, Kurrey NK, Anu-Appaiah KA, Rao RP (2019) Probiotic yeasts inhibit virulence of non-albicans Candida species. MBio 10(5):e02307\u2013e02319","journal-title":"MBio"},{"issue":"2","key":"162_CR21","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1128\/AAC.01214-09","volume":"54","author":"ML Langford","year":"2010","unstructured":"Langford ML, Hasim S, Nickerson KW, Atkin AL (2010) Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. Antimicrob Agents Chemother 54(2):940\u2013942","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"162_CR22","doi-asserted-by":"crossref","first-page":"e00143","DOI":"10.1128\/mBio.00143-15","volume":"6","author":"I Leonhardt","year":"2015","unstructured":"Leonhardt I, Spielberg S, Weber M, Albrecht-Eckardt D, Blass M, Claus R, Barz D, Scherlach K, Hertweck C, L\u00f6ffler J, H\u00fcnniger K, Kurzai O (2015) The fungal quorum sensing molecule farnesol activates innate immune cells but supresses cellular adaptive immunity. mBio 6(2):e00143","journal-title":"mBio"},{"issue":"8","key":"162_CR23","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/myc.12904","volume":"62","author":"SA Lone","year":"2019","unstructured":"Lone SA, Ahmad A (2019) Candida auris\u2014the growing menace to global health. Mycoses 62(8):620\u2013637","journal-title":"Mycoses"},{"issue":"2","key":"162_CR24","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/jam.13513","volume":"123","author":"DR Monteiro","year":"2017","unstructured":"Monteiro DR, Arias LS, Fernandes RA, Deszo da Silva LF, de Castilho MOVF, da Rosa TO0, Vieira APM, Straioto FG, Barbosa DB, Delbem ACB (2017) Antifungal activity of tyrosol and farnesol used in combination against Candida species in the planktonic state or forming biofilms. J Appl Microbiol 123(2):392\u2013400","journal-title":"J Appl Microbiol"},{"key":"162_CR25","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3389\/fmicb.2020.00957","volume":"11","author":"F Nagy","year":"2020","unstructured":"Nagy F, Vit\u00e1lis E, Jakab \u00c1, Borman AM, Forg\u00e1cs L, T\u00f3th Z, Majoros L, Kov\u00e1cs R (2020) In vitro and in vivo effect of exogenous farnesol exposure against Candida auris. Front Microbiol 11:957","journal-title":"Front Microbiol"},{"issue":"1","key":"162_CR26","first-page":"29","volume":"72","author":"BY \u00d6zt\u00fcrk","year":"2019","unstructured":"\u00d6zt\u00fcrk BY (2019) Intracellular and extracellular green synthesis of silver nanoparticles using Desmodesmus sp.: their Antibacterial and antifungal effects. Caryologia. Int J Cytol Cytosyst Cytogenet 72(1):29\u201343","journal-title":"Int J Cytol Cytosyst Cytogenet"},{"key":"162_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.procbio.2019.10.027","volume":"89","author":"BY \u00d6zt\u00fcrk","year":"2020","unstructured":"\u00d6zt\u00fcrk BY, G\u00fcrsu BY, Da\u011f \u0130 (2020) Antibiofilm and antimicrobial activities of green synthesized silver nanoparticles using marine red algae Gelidium corneum. Process Biochem 89:208\u2013219","journal-title":"Process Biochem"},{"issue":"5","key":"162_CR28","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s00253-020-10349-w","volume":"104","author":"E Paluch","year":"2020","unstructured":"Paluch E, Rewak-Soroczy\u0144ska J, J\u0119drusik I, Mazurkiewicz E, Jermakow K (2020) Prevention of biofilm formation by quorum quenching. Appl Microbiol Biotechnol 104(5):1871\u20131881","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"162_CR29","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1203\/PDR.0b013e318232a984","volume":"70","author":"M Pammi","year":"2011","unstructured":"Pammi M, Liang R, Hicks JM, Barrish J, Versalovic J (2011) Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin. Pediatr Res 70(6):578\u2013583","journal-title":"Pediatr Res"},{"key":"162_CR30","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0074-7696(04)42005-1","volume":"242","author":"R Prasad","year":"2005","unstructured":"Prasad R, Kapoor K (2005) Multidrug resistance in yeast Candida. Int Rev Cytol 242:215\u2013248","journal-title":"Int Rev Cytol"},{"issue":"11","key":"162_CR31","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.1128\/AEM.68.11.5459-5463.2002","volume":"68","author":"G Ramage","year":"2002","unstructured":"Ramage G, Saville SP, Wickes BL, L\u00f3pez-Ribot JL (2002) Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68(11):5459\u20135463","journal-title":"Appl Environ Microbiol"},{"issue":"4","key":"162_CR32","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","volume":"4","author":"G Ramage","year":"2005","unstructured":"Ramage G, Saville SP, Thomas DP, L\u00f3pez-Ribot J (2005) Candida biofilms: an update. Eukaryot Cell 4(4):633\u2013638","journal-title":"Eukaryot Cell"},{"issue":"7","key":"162_CR33","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/j.1567-1364.2006.00117.x","volume":"6","author":"G Ramage","year":"2006","unstructured":"Ramage G, Mart\u00ednez JP, L\u00f3pez-Ribot JL (2006) Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res 6(7):979\u2013986","journal-title":"FEMS Yeast Res"},{"issue":"4","key":"162_CR34","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/genes11040444","volume":"11","author":"CF Rodrigues","year":"2020","unstructured":"Rodrigues CF, \u010cern\u00e1kov\u00e1 L (2020) Farnesol and Tyrosol: Secondary metabolites with a crucial quorum-sensing role in Candida biofilm development. Genes 11(4):444","journal-title":"Genes"},{"issue":"7","key":"162_CR35","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1128\/AAC.01438-06","volume":"51","author":"T Rossignol","year":"2007","unstructured":"Rossignol T, Logue ME, Reynolds K, Grenon M, Lowndes NF, Butler G (2007) Transcriptional response of Candida parapsilosis following exposure to farnesol. Antimicrob Agents Chemother 51(7):2304\u20132312","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"162_CR36","first-page":"3201","volume":"19","author":"S Sebaa","year":"2019","unstructured":"Sebaa S, Boucherit-Otmani Z, Courtois P (2019) Effects of tyrosol and farnesol on Candida albicans biofilm. Mol Med Rep 19(4):3201\u20133209","journal-title":"Mol Med Rep"},{"issue":"1","key":"162_CR37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13756-019-0533-3","volume":"8","author":"D Sharma","year":"2019","unstructured":"Sharma D, Misba L, Khan AU (2019) Antibiotics versus biofilm: an emerging battleground in microbial communities. Antimicrob Resist Infect Control 8(1):1\u201310","journal-title":"Antimicrob Resist Infect Control"},{"key":"162_CR38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mib.2014.02.008","volume":"18","author":"C Solano","year":"2014","unstructured":"Solano C, Echeverz M, Lasa I (2014) Biofilm dispersion and quorum sensing. Curr Opin Microbiol 18:96\u2013104","journal-title":"Curr Opin Microbiol"},{"key":"162_CR39","first-page":"204237","volume":"2013","author":"C Spampinato","year":"2013","unstructured":"Spampinato C, Leonardi D (2013) Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed Res Int 2013:204237","journal-title":"Biomed Res Int"},{"issue":"2","key":"162_CR40","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3109\/13693786.2011.580016","volume":"50","author":"HT Taff","year":"2012","unstructured":"Taff HT, Nett JE, Andes DR (2012) Comparative analysis of Candida biofilm quantitation assays. Sabouraudia 50(2):214\u2013218","journal-title":"Sabouraudia"},{"key":"162_CR41","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fmicb.2019.01582","volume":"10","author":"G Wu","year":"2019","unstructured":"Wu G, Yan S (2019) Can Biofilm Be Reversed Through Quorum Sensing in Pseudomonas aeruginosa? Front Microbiol 10:1582","journal-title":"Front Microbiol"},{"issue":"4","key":"162_CR42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/08927014.2017.1295304","volume":"33","author":"J Xia","year":"2017","unstructured":"Xia J, Qian F, Xu W, Zhang Z, Wei X (2017) In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains. Biofouling 33(4):283\u2013293","journal-title":"Biofouling"},{"key":"162_CR43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/TCRM.S40160","volume":"10","author":"N Yapar","year":"2014","unstructured":"Yapar N (2014) Epidemiology and risk factors for invasive candidiasis. Ther Clin Risk Manag 10:95\u2013105","journal-title":"Ther Clin Risk Manag"},{"issue":"12","key":"162_CR44","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4056d03c-20ed-4eca-9568-3e9400e2312e","volume":"6","author":"L Zhang","year":"2011","unstructured":"Zhang L, Chang W, Sun B, Groh M, Speicher A, Lou H (2011) Bisbibenzyls, a new type of antifungal agent, inhibit morphogenesis switch and biofilm formation through upregulation of DPP3 in Candida albicans. PLoS One 6(12):e28953","journal-title":"PLoS One"},{"key":"162_CR45","doi-asserted-by":"crossref","unstructured":"Zhao LX, Li DD, Hu DD, Hu GH, Yan L, Wang Y, Jiang YY (2013) Effect of tetrandrine against Candida albicans biofilms. PLoS One 8(11)","DOI":"10.1371\/journal.pone.0079671"}],"container-title":["International Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-021-00162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10123-021-00162-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10123-021-00162-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T06:56:20Z","timestamp":1618469780000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10123-021-00162-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,18]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["162"],"URL":"https:\/\/doi.org\/10.1007\/s10123-021-00162-4","relation":{},"ISSN":["1139-6709","1618-1905"],"issn-type":[{"value":"1139-6709","type":"print"},{"value":"1618-1905","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,18]]},"assertion":[{"value":"15 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}